Morepen Laboratories informs about outcome of board meeting

05 Aug 2023 Evaluate
Morepen Laboratories has informed that the Board of Directors of the company in their meeting held today Saturday, 5th August, 2023 (commenced at 11:15 AM and concluded at 2:15 PM), have, considered and approved Un-audited standalone and consolidated financial results of the company for the quarter ended 30th June, 2023. Pursuant to Regulation 33 of the SEBI Listing Regulations, a copy of the ‘Results’ along with Limited Review Report of the Statutory Auditors of the company, are enclosed; Re-appointment of Sushil Suri (DIN:00012028) as the Chairman & Managing Director of the company for a further period of 3 years, effective from 20th October, 2023, subject to the approval of the members in the ensuing Annual General Meeting of the company.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

42.42 -1.03 (-2.37%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×